Bayer’s Parkinson’s disease cell therapy is moving into late-stage testing, with the upcoming trial set to be the first registrational phase 3 study for an investigational allogeneic cell ...

NASA's beleaguered Mars Sample Return program currently faces extreme costs of up to $11 billion and a timeline that could reach 2040. The year 2025 isn't even a week old and NASA is already ...

In the United States, Bayer will continue its multipronged strategy to significantly contain the Roundup™ litigation. Having achieved favorable outcomes in 15 of the last 22 trials, the company ...

NASA wants to return Mars samples to Earth, but budget problems and technical woes have the mission caught between a rock and the Red Planet. There appears to be an unofficial robotic space race ...

Despite restructuring efforts, Bayer's financial outlook for 2025 ... Our analysts are third party authors that include both professional investors and individual investors who may not be licensed ...

WASHINGTON – The US government’s recent overhaul of the H-1B visa program marks a transformative step for US businesses and international professionals, including Filipinos seeking opportunities ...